| Studies | Early stage | Advanced stage | Overall | Full name |
---|---|---|---|---|---|
General | |||||
 SF-36 | 21 | 1025 | 436 | 3452 | 36-Item Short Form health survey [s1–s21] |
 WHOQOL-BREF | 9 | 415 | 281 | 963 | WHO Quality of Life – Abbreviated [s22–s30] |
 SF-12 | 8 | 569 | 443 | 1263 | 12-Item Short Form health survey [s31–s38] |
 EQ-5D | 7 | 655 | 363 | 2287 | Euroqol-5D [s21, s39–s44] |
 VR 12 | 1 | 0 | 0 | 1016 | Veterans Rand 12-Item Health Survey [s20] |
 SF8 | 1 | 311 | 218 | 529 | 8-Item Short Form health survey [s43] |
 PROMIS | 4 | 294 | 108 | 565 | Patient Reported Outcomes Measurement Information System [s45–s48] |
 QL-I | 1 | 34 | 45 | 79 | Quality of Life Index [s49] |
 PGWB | 1 | 24 | 22 | 46 | Psychological General Well-Being [s50] |
 ALLTAG | 1 | 24 | 22 | 46 | [German] Questionnaire on everyday life [s50] |
Total | 54 | 3351 | 1938 | 10246 | Â |
Cancer | |||||
 FACT-G | 26 | 634 | 2126 | 3807 | Functional Assessment of Cancer Therapy – General [s15, s33, s51–s74] |
 EORTC QLQ-C30 | 29 | 344 | 561 | 2792 | European Organization for Research and Treatment of Cancer, Quality of Life Questionnaire, Core module [s13, s14, s49, s75–s97] |
 FACT NTX | 3 | 0 | 1108 | 1108 | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity [s69, s70, s72] |
 FACT-GP | 2 | 147 | 54 | 221 | Functional Assessment of Cancer Therapy - General Population [s47, s48] |
 QOL-CS | 2 | 0 | 0 | 72 | Quality of Life – Cancer Survivors [s17, s100] |
 CARES-SF | 1 | 0 | 0 | 129 | Cancer Rehabilitation Evaluation System – Short Form [s93] |
 FACT AN | 1 | 0 | 115 | 115 | Functional Assessment of Cancer Therapy-Anemia [s73] |
 SDCQ | 1 | 0 | 0 | 59 | Socio-demographic and Clinical Questionnaire [s101] |
 MQOLS-CA | 1 | 0 | 0 | 38 | Multidimensional Quality of Life. Scaled Cancer [s102] |
Total | 66 | 1125 | 3964 | 8341 | Â |
Cx specific | |||||
 EORTC QLQ-CX24 | 35 | 3212 | 1508 | 5556 | European Organization for Research and Treatment of Cancer, Quality of Life Questionnaire, Cervical cancer module [s18, s21, s103–s135] |
 FACT-Cx | 22 | 1231 | 2973 | 4224 | Functional Assessment of Cancer Therapy – Cervical cancer [s32, s38, s46–s48 s69–s72, s136–s148] |
Total | 57 | 4443 | 4481 | 9780 | Â |
Other cancer specific | |||||
 Ovarium specific | |||||
   ORTC QLQ-OV28 | 1 | 0 | 0 | 27 | European Organization for Research and Treatment of Cancer, Quality of Life Questionnaire, Ovarian cancer module [s96] |
 Bladder Cancer | |||||
  FACT BL | 1 | 0 | 0 | 13 | Functional Assessment of Cancer Therapy – Bladder cancer [s149] |
 Breast Cancer | |||||
  FACT-B | 1 | 0 | 0 | 10 | Functional Assessment of Cancer Therapy – Breast cancer [s150] |
 Brain Cancer | |||||
  FACT-BR | 1 | 0 | 1 | 1 | Functional Assessment of Cancer Therapy – Brain cancer [s151] |
Total | 4 | 0 | 1 | 51 | Â |
Other | |||||
 Terminal care | |||||
  MVQOLI | 1 | 0 | 32 | 32 | Missoula-VITAS Quality of Life Index [s152] |
 Menopause | |||||
  WHQ 30 | 1 | 0 | 0 | 15 | Woman’s Health Questionnaire [s153] |
 Chronic illness | |||||
  FACT-SP | 2 | 19 | 91 | 114 | Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being [s133, s154] |
  FACT F | 1 | 0 | 1 | 1 | Functional Assessment of Chronic Illness Therapy-Fatigue [s97] |
 Rectal bleeding | |||||
  RBQOLS | 1 | 0 | 0 | 2 | Rectal Bleeding Quality of Life Scale [s155] |
 Fecal incontinence | |||||
  FIQLI | 1 | 0 | 0 | 21 | Fecal Incontinence Quality of Life [s156] |
Total | 7 | 19 | 124 | 185 | Â |
Total Overall a | 156 | 6848 | 7053 | 20690 | Â |